New Roles of Glycosaminoglycans in α-Synuclein Aggregation in a Cellular Model of Parkinson DiseaseSonia Lehri-Boufala, Christophe Morin, Dulce Papy-García et al.|PLoS ONE|2015Cited by 50
A fine structural modification of glycosaminoglycans is correlated with the progression of muscle regeneration after ischaemia: towards a matrix-based therapy?Fabien Chevalier, Patricia Albanese, Hanna Hlawaty et al.|European Cells and Materials|2015Cited by 18
Glycosaminoglycan Modifications in Duchenne Muscular DystrophyElisa Négroni, Patricia Albanese, Emilie Hénault et al.|Journal of Neuropathology & Experimental Neurology|2014Cited by 18